4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0000950170-24-002433
Options or other derivatives
- Chief Executive Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schambye Hans T. Chief Executive Officer | 2024-01-03 | Grant or award · Restricted Stock Units | +200,000 | 200,000 | D | ||
Loading xslF345X05/ownership.xml…